Schizophrenia Research
Volume 119, Issue 1 , Pages 228-231, June 2010

Antipsychotic drug use is correlated with CRP40/mortalin mRNA expression in the dorsolateral prefrontal cortex of human postmortem brain specimens

  • Joseph P. Gabriele

      Affiliations

    • Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada
    • Corresponding Author InformationCorresponding author. McMaster University, 1200 Main St. West, HSC Rm 4N81, Hamilton, Ontario, Canada L8N 3Z5. Tel.: +1 905 525 9140x22617.
  • ,
  • Giuseppe F. Pontoriero

      Affiliations

    • Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada
  • ,
  • Nancy Thomas

      Affiliations

    • Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada
  • ,
  • Mark A. Ferro

      Affiliations

    • Department of Epidemiology and Biostatistics, University of Western Ontario, London, Ontario, Canada
  • ,
  • Geetha Mahadevan

      Affiliations

    • Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada
  • ,
  • Duncan J. MacCrimmon

      Affiliations

    • Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada
  • ,
  • Zdenek B. Pristupa

      Affiliations

    • Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada
  • ,
  • Ram K. Mishra

      Affiliations

    • Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada

Received 15 July 2009; received in revised form 21 December 2009; accepted 29 December 2009. published online 25 January 2010.

Abstract 

Heat shock proteins act as intracellular chaperones by assisting with proper protein folding in response to various cellular stresses. In doing so, these proteins protect the cell from unwanted protein aggregation, which in turn, plays an important role in the pathogenesis of numerous disorders. Previous reports from our laboratory have described a 40kDa catecholamine regulated heat shock-like protein (CRP40), an alternate gene product of the 70kDa mitochondrial heat shock protein, mortalin. CRP40 shares an intimate association with dopaminergic activity, specifically as it pertains to dopamine dysregulation in schizophrenia. This study investigates human CRP40/mortalin mRNA expression within dorsolateral prefrontal cortex postmortem specimens from normal control, schizophrenic and bipolar patients obtained from the Stanley Medical Research Institute. Real-time polymerase chain reaction was carried out for all patient samples (n=105; n=35 per group) in a blinded manner. No significant alterations in CRP40/mortalin mRNA expression levels were observed between control, bipolar and schizophrenic patients. However, multiple regression demonstrated a distinct positive correlation between CRP40/mortalin mRNA expression and lifetime use of antipsychotic drugs within the schizophrenic patient profile, after controlling for important confounding factors. Thus, the data suggest that human CRP40/mortalin is modulated by dopaminergic activity and may act to protect neurons from excess catecholamine activity in regions of the brain associated with psychosis.

Keywords: Schizophrenia, Catecholamine regulated proteins, Mortalin, Prefrontal cortex, Antipsychotic drugs

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0920-9964(10)00006-X

doi:10.1016/j.schres.2009.12.039

Schizophrenia Research
Volume 119, Issue 1 , Pages 228-231, June 2010